"Dementia risks: Deprescribing, hormone therapy, and acid reflux drugs under scrutiny"
A study led by researchers at the Beth Israel Deaconess Medical Center reveals that efforts to deprescribe medications for dementia patients are failing, as there is an increase in overall medication use following a dementia diagnosis. Despite the importance of simplifying medication regimens and reducing adverse drug events, deprescribing guidelines and efforts are not effectively implemented. The study highlights a potential gap in clinical practice and raises concerns about the increased use of central nervous system-active medications, which can adversely affect cognitive function. The findings suggest missed opportunities to reduce burdensome polypharmacy and deprescribe medications with high safety risks or limited likelihood of benefit.
